MAI Capital Management decreased its position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 45.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,662 shares of the semiconductor company’s stock after selling 1,390 shares during the quarter. MAI Capital Management’s holdings in Synopsys were worth $842,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also modified their holdings of the company. ORG Partners LLC grew its holdings in Synopsys by 600.0% in the second quarter. ORG Partners LLC now owns 42 shares of the semiconductor company’s stock valued at $25,000 after purchasing an additional 36 shares during the last quarter. Pacifica Partners Inc. acquired a new stake in Synopsys in the 3rd quarter valued at about $25,000. Tsfg LLC increased its holdings in Synopsys by 75.0% during the 3rd quarter. Tsfg LLC now owns 56 shares of the semiconductor company’s stock valued at $28,000 after acquiring an additional 24 shares in the last quarter. Chris Bulman Inc acquired a new position in Synopsys during the second quarter worth about $30,000. Finally, Hazlett Burt & Watson Inc. lifted its holdings in shares of Synopsys by 40.0% in the third quarter. Hazlett Burt & Watson Inc. now owns 70 shares of the semiconductor company’s stock valued at $35,000 after purchasing an additional 20 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.
Synopsys Stock Performance
SNPS stock opened at $557.73 on Friday. The firm has a market cap of $85.67 billion, a P/E ratio of 57.86, a price-to-earnings-growth ratio of 3.26 and a beta of 1.08. The stock has a 50-day simple moving average of $519.28 and a 200-day simple moving average of $545.55. Synopsys, Inc. has a 1 year low of $457.52 and a 1 year high of $629.38.
Wall Street Analyst Weigh In
A number of research analysts have recently weighed in on the stock. Loop Capital started coverage on shares of Synopsys in a research note on Monday, November 11th. They set a “buy” rating and a $675.00 price objective for the company. JPMorgan Chase & Co. boosted their price target on Synopsys from $655.00 to $685.00 and gave the stock an “overweight” rating in a report on Thursday, August 22nd. Berenberg Bank assumed coverage on Synopsys in a research report on Tuesday, October 15th. They issued a “buy” rating and a $660.00 price objective on the stock. Needham & Company LLC reiterated a “buy” rating and set a $640.00 price objective on shares of Synopsys in a research report on Tuesday, October 22nd. Finally, Robert W. Baird upped their target price on shares of Synopsys from $661.00 to $663.00 and gave the company an “outperform” rating in a report on Thursday, August 22nd. Twelve investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Synopsys has an average rating of “Buy” and an average target price of $649.82.
View Our Latest Analysis on SNPS
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Further Reading
- Five stocks we like better than Synopsys
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
- Energy and Oil Stocks Explained
- 3 Rock-Solid Buying Opportunities in the Market Right Now
- 3 Healthcare Dividend Stocks to Buy
- TJX Companies Stock Poised to Hit a New High This Year
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.